India IVF (in-vitro fertilization) Market Overview, 2029

India IVF (in-vitro fertilization) Market Overview, 2029

India has been a major leader in the field of in vitro fertilisation (IVF) in recent years, which has revolutionised the treatment of reproductive healthcare. The demand for in vitro fertilisation (IVF), a groundbreaking treatment that helps couples overcome infertility obstacles, has significantly increased in the Indian healthcare system. Numerous causes, such as growing knowledge, improvements in medical technology, and shifting public perceptions of assisted reproductive technologies, are driving this increase. The Indian IVF market shows a vibrant and quickly changing environment. The need for IVF and other infertility treatments has significantly increased due to the growing population and rising incidence of infertility. The IVF market in India has drawn both foreign and indigenous firms, creating a competitive atmosphere with the goal of improving service quality and increasing accessibility. This competitive environment has aided in the development of technology and expanded the range of therapy choices available to a wider range of patients. The IVF industry has grown dramatically as a result of India's status as a centre for medical tourism. International individuals seeking fertility treatments have been drawn to the nation because of its reputation for providing high-quality healthcare at relatively reduced charges. This trend has improved IVF clinics' revenue sources while also promoting information sharing and international cooperation, which has enhanced the ecosystem as a whole. The regulatory structure of the IVF industry in India is one of its unique characteristics. In order to guarantee the security, effectiveness, and moral performance of IVF treatments, the nation has set up regulating organisations and policies. These rules are intended to protect patients' interests while encouraging industry innovation and ethical behaviour. By providing subsidies and other incentives to support reproductive healthcare, the Indian government has taken action to increase the accessibility and affordability of fertility treatments. The Indian IVF market has promise and is growing quickly, but there are significant obstacles to overcome. These include the sociocultural stigmas associated with infertility, regional differences in healthcare service accessibility, and the ongoing need to invest in infrastructure and trained labour. In order to address these issues, governments, healthcare professionals, and the general public must work together to foster an environment that supports the goals of family planning and reproductive health.

According to the research report, ""India Infertility Treatment Market Overview, 2029,"" published by Bonafide Research, the India Infertility Treatment market is anticipated to add to more than USD 46 Million by 2024–29. In vitro fertilisation (IVF) has made great strides in India in recent years, thanks to a number of important breakthroughs. First off, there is a growing number of advanced reproductive clinics and centres around the nation that are manned by highly qualified medical specialists and furnished with the newest technology available. Second, a greater proportion of the population may now more easily receive IVF procedures due to a noticeable rise in their affordability and accessibility. Furthermore, in the IVF industry, India has become a global centre for medical tourism, drawing people from all over the world who are looking for high-quality but reasonably priced reproductive procedures. A number of variables, including as improvements in medical technology, pro-reproductive government legislation, and rising public knowledge and acceptance of assisted reproductive procedures, have contributed to the development in the Indian IVF industry. Given the increasing demand for infertility treatments and India's growing prominence in the global fertility market, this development trajectory is probably here to stay.

India has a varied environment when it comes to assisted reproductive technology (ART), which reflects a range of tastes, developments, and socioeconomic issues. Different IVF cycle types appeal to different segments of the Indian population and each has unique benefits. In the Fresh Non-donor IVF Cycle, the prospective mother's ovaries are stimulated to create numerous eggs, which are then removed and fertilised with sperm in a lab. Because of its efficacy and the need for a biological bond between mother and kid, this kind of cycle has long been favoured in India. Couples may experience the entire procedure together, from egg harvesting to embryo transfer, which promotes connection and a sense of involvement. Due to worries about the possibility for multiple pregnancies and the physical effects of ovarian stimulation, despite its popularity, its rise has largely plateaued in recent years. On the other hand, the Frozen Non-donor IVF Cycle has been more popular in India lately. Using this method, embryos generated from a prior fresh IVF round are frozen and then transferred into the uterus during a later cycle. It has a number of benefits, such as cheaper expenses, less prescription needs, and the option to plan the embryo transfer for the best uterine receptivity. In addition, it reduces the requirement for ovarian stimulation, which allays worries over its adverse consequences. The cycle type of frozen embryo transfers is becoming more and more popular among Indian couples seeking fertility treatments because of its ease and high success rates. Utilising egg donations or sperm, frozen donor embryos are used in in vitro fertilisation cycles. This choice is appealing to infertile couples in whom the fertility of one or both partners may be impaired. In India, where there is a cultural focus on biological lineage and the desire for genetically related children, the use of donor embryos enables people to overcome medical obstacles and achieve motherhood. This cycle type is becoming more and more popular in the nation due to the availability of donor embryos and improvements in cryopreservation methods. IVF cycles with fresh donors have been performed in India, however they are not as common as other cycle types. With this method, donor eggs are stimulated and recovered, and then they are fertilised using either the partner's or the donor's sperm. Although fresh egg donation has excellent success rates, its general acceptance has been somewhat hampered by the logistical and ethical issues surrounding it, including donor availability, cycle synchronisation, and potential legal complications. But with to rising awareness, changing laws, and better infrastructure, the use of new donor cycles is steadily growing in India.

Conventional IVF is still a commonly used assisted reproductive technology (ART) procedure in India. With this method, sperm and eggs are fertilised in a lab dish, and the resultant embryos are then transferred into the uterus. For many years, it has been a mainstay of infertility therapy in India, giving hope to couples dealing with a range of reproductive problems. Conversely, IVF in conjunction with ICSI (Intracytoplasmic Sperm Injection) has been increasingly popular in the Indian ART market in recent years. This method, which is especially helpful in situations of male factor infertility, entails injecting a single sperm directly into an egg to aid in fertilisation. Due to its accuracy in treating problems pertaining to sperm, Indian couples pursuing fertility therapy are finding it more and more popular. In India, IVF with donor eggs has become a popular choice for couples who are having problems with the quality or quantity of their eggs. With this technique, eggs from a different woman—usually a younger donor—are used. The partner's sperm is then fertilised using either traditional IVF or ICSI. This method's increasing acceptability in the Indian fertility scene may be attributed to the fact that it offers a workable option to couples who might not be able to conceive using their own eggs. Fertility treatments in India are progressively using additional specialised procedures and developments in IVF, such as preimplantation genetic testing and embryo freezing (cryopreservation). With improved accuracy, effectiveness, and success rates, these advancements provide Indian couples considering ART even more alternatives.
The medical services environment in India is as varied as the country, with each industry leaving its mark in a special way. In response to India's increasing need for assisted reproductive technologies (ART), fertility clinics stand out as innovators. Fertility clinics have experienced a notable increase in demand due to rising awareness of infertility difficulties and breakthroughs in reproductive medicine. India's fertility clinics serve a wider demographic by offering individualised care and cost-effective treatment alternatives in addition to a comprehensive variety of ART treatments. Fertility clinics will be at the forefront of India's healthcare sector as more couples look for answers to their infertility-related problems. Hospitals and surgical centres are the main providers of healthcare for millions of people in India, making them extremely important to the country's healthcare system. These facilities provide a broad range of medical services, from simple checkups to intricate surgical operations. The ageing population and the growth in illnesses linked to a poor lifestyle have increased demand for high-quality healthcare services from hospitals and surgical centres. Furthermore, the rise of medical tourism has accelerated the expansion of this industry, with India becoming as a top choice for reasonably priced and excellent medical care. Hospitals and surgical centres are therefore still mainstays in India's healthcare industry, ready for continued growth and innovation. Cryobanks are a small but rapidly growing part of the Indian healthcare industry. These facilities are essential for the preservation of biological material, including sperm, eggs, and embryos, for a range of applications such as illness management, research, and fertility therapy. The need for cryopreservation services has increased recently due to a number of circumstances, including growing recognition of the value of genetic banking, developments in stem cell research, and an increase in lifestyle disorders. Indian cryobanks have improved their services by utilising technology innovations to provide safe, effective storage options that meet global quality requirements. As the potential uses for cryopreserved biological material become more widely acknowledged, cryobanks are expected to experience significant expansion in the years to come. The foundation of scientific and medical progress in India is provided by research institutes, which have a major impact on the nation's healthcare system. These institutions carry out innovative research in a number of fields, including as pharmacology, biotechnology, and medicine.

 

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• IVF market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By cycle
• Fresh Non-donor IVF Cycle
• Frozen Non-donor IVF Cycle
• Frozen donor IVF Cycle
• Fresh donor IVF Cycle

By Conventional IVF
• Conventional IVF
• IVF with ICSI (Instracytoplasmic Sperm Injection)
• IVF With Donor Eggs
• other

By End user
• Fertility Clinics
• Hospital & Surgical Centers
• Cryobanks
• Research institute

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.